HemoCath™ is a breakthrough medical device that will transform heart failure (HF) management. It is uniquely designed to be an easy-to-use flow-directed right heart catheter for DIRECT MONITORING of pulmonary artery (PA) pressure and central venous pressure (CVP), therefore providing PRECISE and IMMEDIATE metrics of fluid status in HF patients.

​HemoCath will allow clinicians to monitor over several hours/days the two most important measures of fluid status in HF patients  —  PA pressure and CVP.  

HemoCath Uniquely Designed for Safe and Effective Heart Failure Management  

​​​Direct monitoring of PA pressure and CVP in HF patients will allow more accurate medication dosing  –  Improving patient outcomes  –  Reducing hospitalizations and 30-day hospital readmissions. 

HemoCath Designed to be Easily Available to Patients

HemoCath will easily be inserted in a vein in patient's upper arm. In most cases, there should be no need for an operating room or medical imaging.